These findings suggest that P111 and/or P121 may suppress proinflammatory cytokine expression in the gut, liver, and brain by suppressing LPS-linked NF-κB signal, leading to the alleviation of colitis, hepatitis, neuroinflammation, and psychiatric disorders. The gene discussed is NFKB1; the disease is colitis.